SVKC Pharmaceuticals Private Limited
About SVKC Pharmaceuticals Private Limited
Data last updated:
SVKC Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 April 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2022PTC380866.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Koushala Ram Potaliya and Rajo Kumari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Fl406 Pl 40 Sect 20 Taloja Phase 2 Olive Paradis Panvel Raigad Navi Mumbai, Maharashtra, India – 410206.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.97 Lakh. For the same year it recorded a net profit of ₹57,800 (net margin 2.5%) and EBITDA of ₹68,483 (EBITDA margin 3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
SVKC Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressFl406 Pl 40 Sect 20 Taloja Phase 2 Olive Paradis Panvel Raigad Navi Mumbai, Maharashtra, India – 410206
- IndustryChemicals, Manufacturing, Fine Chemicals And Other Chemical Products, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SVKC Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of SVKC Pharmaceuticals Private Limited, buy the company report.
Financials of SVKC Pharmaceuticals Private Limited
FY 2024 filings availableSVKC Pharmaceuticals Private Limited reported revenue of ₹22.97 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹68,483 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹57,800 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3% | |
| Net Profit Margin | 2.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of SVKC Pharmaceuticals Private Limited, buy the company report.
Board of directors of SVKC Pharmaceuticals Private Limited
SVKC Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koushala Ram Potaliya | Director | 19 Apr 2022 | 4 Years 6 Months | Current |
| Rajo Kumari Also directs: Mahadhyuta Infra Projects LLP, Mahasuraj Infra Private Limited | Director | 19 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
SVKC Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Airmed Pharmaceuticals (India) Private Limited | ₹23.09 Lakh (FY 2020) | -47.0% | Hyderabad, Telangana, India | |||
| Argor Pharmaceuticals Private Limited | ₹23 Lakh (FY 2024) | 73.0% | Chennai, Tamil Nadu, India | |||
| SVKC Pharmaceuticals Private Limitedthis company | ₹22.97 Lakh (FY 2024) | ₹57,800 | 2.5% | Mumbai, Maharashtra, India | ||
| Annpride Pharmaceuticals Private Limited | ₹22.83 Lakh (FY 2016) | New Delhi, Delhi, India | ||||
| Ragnia Pharmaceuticals Private Limited | ₹22.8 Lakh (FY 2024) | 248.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of SVKC Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving SVKC Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SVKC Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for SVKC Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
SVKC Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Mayank Bhatnagar ceased to be Additional Director on 29 Dec 2023.
Frequently asked questions
SVKC Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 April 2022 (4+ years old) and is registered under CIN U24299MH2022PTC380866.
SVKC Pharmaceuticals has 2 current directors:
- Koushala Ram Potaliya - Director
- Rajo Kumari - Director
The latest financial statements of SVKC Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of SVKC Pharmaceuticals is U24299MH2022PTC380866. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SVKC Pharmaceuticals was incorporated on 19 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of SVKC Pharmaceuticals by revenue are Airmed Pharmaceuticals (India) Private Limited, Argor Pharmaceuticals Private Limited, Annpride Pharmaceuticals Private Limited, Ragnia Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mayank Bhatnagar ceased to be Additional Director on 29 Dec 2023. Koushala Ram Potaliya was appointed as Director on 19 Apr 2022. Rajo Kumari was appointed as Director on 19 Apr 2022.
The registered office of SVKC Pharmaceuticals is at Fl406 Pl 40 Sect 20 Taloja Phase 2 Olive Paradis Panvel Raigad Navi Mumbai, Maharashtra, India – 410206.
SVKC Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of SVKC Pharmaceuticals is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.
SVKC Pharmaceuticals can be reached at its registered office: Fl406 Pl 40 Sect 20 Taloja Phase 2 Olive Paradis Panvel Raigad Navi Mumbai, Maharashtra, India – 410206.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
